ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Otsuka Pharmaceutical Development and Commercialization at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Otsuka Pharmaceutical Development and Commercialization brings 2 presentations to ACR Convergence 2026 in Orlando. Its program covers real-world claims and symptom data, including the economic burden of ANCA-associated vasculitis and organ involvement patterns across subgroups of Sjögren's disease.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
OP Otsuka Pharmaceutical Development and Commercialization | |
Otsuka subsidiary supporting pharmaceutical development and commercialization. | Poster Mon Nov 9 10:30am–12:30pm |
Find decision makers at Otsuka Pharmaceutical Development and Commercialization
Tell us what you sell and we’ll find the people at Otsuka Pharmaceutical Development and Commercialization most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction